Medical speaker and KOLs presentation design helps pharmaceutical and biotech teams communicate clinical evidence clearly during congresses, advisory boards, and scientific meetings. We develop editable PowerPoint presentations that help speakers deliver complex scientific content with confidence and structure.
Editable and animated PowerPoint presentations.
Designed for congress presentations, KOL symposia, advisory boards, and physician education sessions.
Structured for scientific clarity,clinical data visibility, and confident live delivery.

KOL presentations carry scientific weight that generic presentation design cannot support. These are the three most common gaps we resolve before a congress or advisory board session.
The teams behind every KOL and medical speaker need a presentation that is ready before they walk into the room.
Used for KOL speaker programs, advisory board facilitation, and scientific exchange activities. Medical affairs teams receive editable, compliant presentations aligned to scientific communication standards.
Used for speaker bureau programs, congress communication, and therapeutic area education at scientific meetings. Brand teams receive consistent presentation assets aligned with launch messaging, therapeutic area communication, and congress speaker programs.
Used for congress presentations, symposium sessions, and physician education events. The speaker receives a complete presentation built around their evidence, their narrative, and their delivery style.
Every project includes an editable KOL presentation, scientific data figures, and a congress handout with speaker notes.
Our process is built on scientific communication practice and pharma presentation workflows. Every stage balances scientific accuracy, communication clarity, and speaker confidence before the presentation reaches the congress stage.
We receive the speaker briefing, congress objectives, existing slide materials, clinical data files, and any brand or compliance guidelines. We review all materials before any design work begins, so the presentation is built on a complete scientific brief and a clear understanding of the speaker's goals.
We review the clinical content and scientific evidence, then develop three presentation concepts showing different ways to organize the science, narrative, and visual structure for live delivery. The speaker and the medical team choose the direction that works best.
We present the chosen concept to the speaker and relevant stakeholders. Revision rounds continue until the scientific narrative is accurate, the structure is approved, and the speaker is confident presenting it on stage.
We deliver the final editable PowerPoint presentation with speaker notes and a slide index. The speaker and the team receive a presentation ready for review, rehearsal, and congress delivery.
Here you are a list of the questions we frequently hear from our customers
Mechanism of action content is built as a visual sequence rather than a single dense slide. Each step is paced for live explanation, with animation guiding the audience through binding, signaling, or pathway interactions. The KOL can explain the science clearly without competing with the visual.
Every KOL presents differently. Some speakers prefer highly visual slides with minimal text, while others rely on detailed data summaries and structured discussion prompts. We adapt slide density, pacing, and visual structure to match how the speaker naturally presents, so the final presentation feels owned by the KOL rather than imposed on them.
We can work directly with the speaker, with the pharmaceutical company, or with both together. The workflow depends on how speaker programs are managed within the organization. Our role is to ensure the final presentation reflects both the scientific objectives of the sponsor and the presentation style of the speaker.
We work from the source materials provided by the medical team, including clinical study reports, published data, and approved references. All scientific claims, data figures, and referenced findings are carried through from those materials without interpretation or modification. The medical team reviews and approves all content at every stage before the presentation is finalized.
Confidential clinical results, unpublished data, and sensitive scientific materials are managed under signed confidentiality agreements. Working files remain restricted to the designated project team throughout the engagement.
Yes. Every KOL presentation is built with a flexible slide structure so content can be expanded, shortened, or reordered for different meeting formats. The same file works across symposia, advisory boards, and speaker bureau meetings without rebuilding it from the start.
AI tools can produce slides quickly but cannot validate clinical data, manage medical legal review, or adapt to the speaking style of an individual KOL. A congress presentation built without scientific oversight carries real credibility risk for the speaker and the sponsoring organization. Every presentation we build is developed specifically for the speaker, the science, and the congress audience.
No. Every visual, diagram, and layout is created specifically for the project. We do not use stock illustration libraries, imagery generated by AI, or external template assets in materials delivered for congress, symposium, or advisory board communication. All files are original and ready for congress, symposium, and advisory board use.
Project schedules depend on the complexity of the scientific content, the number of review stakeholders, and the congress date. We confirm a project schedule at the start of every congress presentation engagement, so the speaker and the medical team have a clear timeline for review, revision, and final delivery.
Yes. Every project includes structured revision rounds at each stage of the process. We present three initial concepts, incorporate feedback after the first review, and continue refining until the speaker and the medical team are satisfied with the final presentation. Changes requested outside the agreed project scope are discussed and quoted separately.